secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pharma-Bio Serv, Inc. (PBSV)
CIK:        0001304161
Form:       8-K
Filed at:   2023-06-14T23:59:59+00:00
Accession:  0001654954-23-008031
Event type: earnings
Sentiment:  positive
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pharma-Bio Serv Q2 net income rises to $0.4M; revenue falls 8% to $4.6M
-----------------------------------------------------------------------

- Revenue for three months ended Apr 30, 2023: $4.6M, down $0.4M YoY.
- Net income for Q2 was $0.4M, up $0.2M from prior year; H1 net income $0.8M, up $0.3M.
- Gross profit margin improved 5.0 percentage points in Q2 and 4.8 ppts in H1.
- CEO cites strategy to focus on most profitable markets and grow presence.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1304161/000165495423008031/0001654954-23-008031-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1304161/000165495423008031/pbsv_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-008031

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer